China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...

Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its ...

Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of ...

Additionally, the long-read sequencing market ... instrument sales and higher consumables pull-through. Illumina’s introduction of the MiSeq i100 series demonstrates the company’s commitment ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

The company recently announced the MiSeq i100 series ... and competitive positioning in the global sequencing market. Illumina's emphasis on reducing the total cost of sequencing, rather than ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...

Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country. Previously ...

SHANGHAI, March 4 (Reuters) - China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina (ILMN.O), opens new tab ...

Illumina Inc's NovaSeq X Plus gene sequencing system is shown in this undated handout photo obtained by Reuters ...

SAN DIEGO, March 6, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array ... in 2024 with the launch of the MiSeq i100 Series, which included key ...